Bipolar disorder therapeutics market seen reaching $10.39 billion by 2030

The bipolar disorder therapeutics market is projected to grow from $7.82 billion in 2025 to $10.39 billion by 2030, driven by rising diagnosis rates, broader psychiatric care and new treatment approaches. North America held the largest share in 2025, while Europe is expected to grow fastest through 2030.

Why it matters: - The bipolar disorder therapeutics market is expanding as mental health awareness rises and treatment options broaden. - Growth in this market tracks with higher diagnosis rates, more psychiatric care access and greater healthcare spending. - The market outlook points to sustained demand for medications, counseling and newer digital and precision-psychiatry tools.

What happened: - The Business Research Company published its Bipolar Disorder Therapeutics Global Market Report 2026, covering market size, trends and forecasts through 2035. - The market is projected to rise from $7.82 billion in 2025 to $8.28 billion in 2026. - The report puts the market at $10.39 billion by 2030. - The report uses a 5.9% compound annual growth rate for both the 2026 and 2030 projections. - North America held the largest market share in 2025. - Europe is expected to be the fastest-growing region over the forecast period.

The details: - Bipolar disorder therapeutics include mood stabilizers, antidepressants, antipsychotic medications and psychological counseling. - Historical growth reflects rising bipolar disorder diagnoses, broader mental health awareness, expanded psychiatric care services, established drug treatments and higher healthcare spending. - Forecast growth is tied to demand for precision psychiatry, wider use of long-acting injectable therapies, more digital therapeutics and stronger focus on treatment adherence. - Rising investment in mental health research is also expected to support market expansion. - Key trends expected in the market include novel mood stabilizers, greater use of atypical antipsychotic medications, more personalized mental health treatment, more combination drug therapies and stronger digital mental health support integration. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - A free sample is available here. - The full report is available here.

Between the lines: - The market forecast suggests bipolar disorder treatment is moving beyond standard medication toward more tailored and digitally supported care. - The emphasis on adherence, injectable therapies and precision psychiatry signals a push to improve long-term outcomes, not just symptom control. - Higher healthcare spending can lift adoption of treatment options, but the report does not identify which markets will absorb the most spending gains.

What's next: - The report expects the market to keep growing steadily through 2030 at 5.9% annually. - Future growth will likely depend on uptake of personalized therapies, digital tools and combination treatments. - Regional competition may sharpen as Europe grows faster while North America remains the largest market. - The Business Research Company says future editions will continue to add deeper market intelligence and updated forecasting tools.